The civic body has identified six densely-populated eastern and western suburbs in the city as high-risk areas for drug-resistant tuberculosis (TB).
More than 100 drug-resistant tuberculosis cases are reported from these municipal wards, which include Dadar (G-north), Malad (P-north), Sion (F-north), Govandi (M-east) Ghatkopar (north) and Vikhroli (south).
The Brihanmumbai Municipal Corporation (BMC) health department aims to increase their efforts in searching, testing and treating patients. Starting this weekend, it will conduct regular health camps in these areas.
The newly-instituted Gene-Xpert diagnostic machinery at Shatabdi Hospital, Govandi, has detected 50 drug-sensitive TB cases and 12 multidrug-resistant TB cases, out of the 83 people who have been tested there.
"By increasing the machinery, we intend to test as many patients as possible. We want to try and diagnose them early and encourage them to continue the treatment," said Manisha Mhaiskar, additional municipal commissioner, BMC.
"We want to ensure that patients suffering from drug-sensitive pulmonary TB complete the six-month long treatment, which will automatically help control drug-resistant TB," she said.
Six municipal wards comprising Byculla, Parel, Andheri (East and West), Kurla and Chembur have been identified as high-risk wards for drug sensitive TB.
Ahead of World TB Day on March 24, the BMC, on Friday launched a 'Mumbai mission for TB control' booklet, which highlights its plans to control the epidemic of drug-resistant TB.
Dr Nata Menabde, WHO representative to India, applauded Mumbai's efforts to control TB. "Drug-resistant TB is spreading fast. If we don't tackle it now, we won't be able to control it in future," said Dr Menabde.